Mandrake Bio - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2025, Mandrake Bio operates in Health Tech offering innovative solutions by harnessing the intersection of AI and structural biology to accelerate the creation of de novo proteins. The comp...
Funding stage:
Pre-Seed
Last funding:
15/07/2026
Total funding:
$1.70 Mn+
Investors
Mandrake Bio: Funding Highlights
Funding highlights of Mandrake Bio and a snapshot of its key metrics.
Total Funding$1.70 Mn+
Current StageEarly Stage
Total Round(s)1
Funding Rounds
FAQs on Funding of Mandrake Bio
Health Tech Funded Mandrake Bio has raised a total funding of $1.70 million as of 16 July 2026 across 1 rounds. Find the details around funding rounds, participating investors, and other insights of Mandrake Bio here...
Mandrake Bio has raised a total of $1.70 million across 1 funding rounds and the last round was raised on 16 July 2026.
Mandrake Bio's key investors include Activate, Antler, DeVC and 2 others.
Mandrake Bio's latest funding round was $1.70 million in Early Stage, raised on 16 July 2026.
Mandrake Bio is at the Early stage. Its most recent round was raised on 16 July 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links